Molecular Partners Ag ADR (MOLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 117,361 | 142,627 |
| Marketable Securities | 43,588 | 42,664 |
| Receivables | 7,773 | 3,026 |
| Other current assets | 0 | 1,337 |
| TOTAL | $181,066 | $189,654 |
| Non-Current Assets | ||
| PPE Net | 9,879 | 21,384 |
| Intangibles | 328 | 0 |
| Other Non-Current Assets | 0 | 370 |
| TOTAL | $10,207 | $21,754 |
| Total Assets | $191,273 | $200,037 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 10,641 | 6,213 |
| Accrued Expenses | 7,884 | 8,232 |
| Other current liabilities | 43,729 | 45,808 |
| TOTAL | $63,559 | $61,511 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 22,968 | 17,724 |
| TOTAL | $22,968 | $17,724 |
| Total Liabilities | $86,527 | $85,676 |
| Shareholders' Equity | ||
| Common Shares | 3,223 | 3,109 |
| Retained earnings | -230,448 | -208,173 |
| Other shareholders' equity | 0 | 1 |
| TOTAL | $104,746 | $114,361 |
| Total Liabilities And Equity | $191,273 | $200,037 |